Brief: Panacea Biotec Says Receipt Of Manufacturing License for Sputnik V Vaccine
04/07/2021 14:09
July 4 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* PANACEA BIOTEC ANNOUNCES RECEIPT OF MANUFACTURING LICENSE
* PANACEA BIOTEC-RECEIPT OF MANUFACTURING LICENSE FROM DRUGS
CONTROLLER GENERAL FOR SPUTNIK V VACCINE AGAINST COVID-19
* PANACEA BIOTEC-LICENSE IS A NECESSARY CONDITION FOR USING
SPUTNIK V VACCINE PRODUCED BY PANACEA BIOTEC IN INDIA
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility